← FDA DRUG APPROVALS

FDA ANDA · ANDA090288

NARATRIPTAN

Sponsor: CHARTWELL RX

APPLICATION
ANDA090288
TYPE
ANDA
ORIGINAL APPROVAL
2010-07-07
LATEST ACTION
2015-09-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

NARATRIPTANDiscontinued
NARATRIPTAN HYDROCHLORIDE EQ 1MG BASE · TABLET · ORAL
NARATRIPTANDiscontinued
NARATRIPTAN HYDROCHLORIDE EQ 2.5MG BASE · TABLET · ORAL

Approval history

2015-09-22Labeling · Supplement 9 · standardAP
2013-08-30Labeling · Supplement 2 · standardAP
2010-07-07OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →